2023 Biologics & Advanced Therapies Contract Manufacturing Report
Get the latest Biologics & Advanced Therapies Contract Manufacturing insights
This report investigates the current trends in Biologics and Advanced Therapies (ATs) industry. In recent years, Biologics and ATs have emerged as the primary drivers of innovation within the pharmaceutical industry. This area has produced blockbuster drugs and holds promising prospects in areas with significant unmet medical needs, such as immunology and immuno-oncology.
Download the 2023 Biologics & Advanced Therapies Contract Manufacturing Report to learn about industry trends, mergers and acquisitions (M&A) activities, and projected growth.